El interés corto en Cartesian Therapeutics Inc (NASDAQ:RNAC) ha disminuido durante el último período de informe, aumentando en descenso desde 2.36M hasta 2.33M. Esto representa el 22.53% de las acciones disponibles públicamente de la empresa.
El interés en corto en Cartesian Therapeutics Corp (XNAS:RNAC) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 52.35K acciones negociadas por día, tomaría 44.53 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. C | 09/15/2025 | 09/24/2025 | 22.53% | 10,348,881 | 2,331,102 | 52,354 | 44.53 | |
RNAC | Cartesian Therapeutics, Inc. C | 08/29/2025 | 09/10/2025 | 22.85% | 10,348,881 | 2,364,831 | 52,056 | 45.43 | |
RNAC | Cartesian Therapeutics, Inc. C | 08/15/2025 | 08/26/2025 | 22.88% | 10,348,881 | 2,367,515 | 46,316 | 51.12 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/31/2025 | 08/11/2025 | 23.60% | 10,348,881 | 2,442,330 | 61,536 | 39.69 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/15/2025 | 07/24/2025 | 25.23% | 10,301,130 | 2,599,153 | 82,757 | 31.41 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/30/2025 | 07/10/2025 | 24.86% | 10,301,130 | 2,561,225 | 78,874 | 32.47 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/13/2025 | 06/25/2025 | 25.51% | 10,301,130 | 2,627,712 | 65,664 | 40.02 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/30/2025 | 06/10/2025 | 24.77% | 10,301,130 | 2,551,444 | 62,274 | 40.97 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/15/2025 | 05/27/2025 | 24.33% | 10,301,130 | 2,506,042 | 87,262 | 28.72 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/30/2025 | 05/09/2025 | 15.41% | 16,449,283 | 2,534,226 | 69,138 | 36.65 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/15/2025 | 04/25/2025 | 14.49% | 16,449,283 | 2,383,018 | 162,762 | 14.64 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/31/2025 | 04/09/2025 | 12.75% | 16,449,283 | 2,097,191 | 103,188 | 20.32 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/14/2025 | 03/25/2025 | 12.34% | 16,449,283 | 2,030,051 | 89,343 | 22.72 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/28/2025 | 03/11/2025 | 12.92% | 16,267,488 | 2,101,196 | 69,762 | 30.12 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/14/2025 | 02/26/2025 | 12.43% | 16,267,488 | 2,022,042 | 52,131 | 38.79 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/31/2025 | 02/11/2025 | 12.11% | 16,267,488 | 1,969,856 | 70,021 | 28.13 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/15/2025 | 01/27/2025 | 12.35% | 16,267,488 | 2,008,843 | 110,341 | 18.21 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/31/2024 | 01/10/2025 | 12.57% | 15,957,080 | 2,006,013 | 162,687 | 12.33 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/13/2024 | 12/24/2024 | 11.26% | 15,957,080 | 1,796,563 | 144,967 | 12.39 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/29/2024 | 12/10/2024 | 11.47% | 15,957,080 | 1,830,389 | 96,571 | 18.95 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/15/2024 | 11/26/2024 | 11.65% | 15,957,080 | 1,859,311 | 132,838 | 14 | |
RNAC | Cartesian Therapeutics, Inc. C | 10/31/2024 | 11/11/2024 | 13.35% | 14,438,707 | 1,928,027 | 68,723 | 28.06 | |
RNAC | Cartesian Therapeutics, Inc. C | 10/15/2024 | 10/24/2024 | 13.47% | 14,438,707 | 1,944,921 | 168,675 | 11.53 | |
RNAC | Cartesian Therapeutics, Inc. C | 09/30/2024 | 10/09/2024 | 17.24% | 11,929,731 | 2,056,590 | 79,916 | 25.73 | |
RNAC | Cartesian Therapeutics, Inc. C | 09/13/2024 | 09/24/2024 | 17.17% | 11,929,731 | 2,047,777 | 68,785 | 29.77 | |
RNAC | Cartesian Therapeutics, Inc. C | 08/30/2024 | 09/11/2024 | 16.87% | 11,924,667 | 2,012,008 | 84,759 | 23.74 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/31/2024 | 08/09/2024 | 35.63% | 5,601,233 | 1,995,614 | 107,689 | 18.53 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/15/2024 | 07/24/2024 | 35.65% | 5,601,233 | 1,996,754 | 371,504 | 5.37 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 20.67% | 5,581,048 | 1,153,831 | 159,772 | 7.22 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 40.21% | 2,017,801 | 811,442 | 90,124 | 9 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 44.77% | 2,017,801 | 903,327 | 87,138 | 10.37 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 47.00% | 2,017,801 | 948,355 | 87,020 | 10.9 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 38.87% | 2,017,801 | 784,229 | 92,534 | 8.48 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 31.65% | 2,017,801 | 638,538 | 140,384 | 4.55 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 54.47% | 16,142,168 | 8,793,275 | 710,905 | 12.37 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 7.36% | 112,820,073 | 8,304,750 | 889,219 | 9.34 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 5.77% | 112,820,073 | 6,515,156 | 541,151 | 12.04 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 5.46% | 112,799,276 | 6,163,818 | 459,811 | 13.41 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 5.43% | 110,866,587 | 6,021,676 | 503,205 | 11.97 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 5.16% | 110,866,587 | 5,722,569 | 820,427 | 6.98 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 4.54% | 110,866,587 | 5,032,380 | 878,410 | 5.73 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 4.26% | 110,866,587 | 4,721,747 | 1,273,825 | 3.71 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/30/2023 | 12/11/2023 | 4.71% | 110,866,587 | 5,220,286 | 1,009,272 | 5.17 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/15/2023 | 11/27/2023 | 6.85% | 110,866,587 | 7,595,047 | 892,455 | 8.51 |
En busca de los valores más cortos?